CARGO Therapeutics, Inc.·4

Sep 20, 5:23 PM ET

Radhakrishnan Anup 4

4 · CARGO Therapeutics, Inc. · Filed Sep 20, 2024

Insider Transaction Report

Form 4
Period: 2024-09-18
Transactions
  • Sale

    Common Stock

    2024-09-18$25.28/sh1,600$40,4526,446 total
  • Exercise/Conversion

    Common Stock

    2024-09-18$5.03/sh+1,600$8,0488,046 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-09-181,60053,180 total
    Exercise: $5.03Exp: 2033-04-20Common Stock (1,600 underlying)
Footnotes (3)
  • [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 28, 2024.
  • [F2]This transaction was executed in multiple trades in prices ranging from $25.25 to $25.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]25% of the shares subject to the option vest on the first anniversary measured from February 9, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file
  • 4
    form4.xmlPrimary